North Dakota

ETC Awarded Contract from the University of North Dakota’s John D. Odegard School of Aerospace Sciences

Retrieved on: 
Wednesday, November 17, 2021
News, ETC, Aerospace physiology, GAT, Illusion, FAA, University, Motion, Student, Human, Aircraft, SD, John D. Odegard School of Aerospace Sciences, North Dakota, Research, GLOBE, OTC Markets Group, Curriculum, UND, Atmosphere, Aviation, Steam, Airline

The GAT-HELO is ETC's most cost-effective, helicopter simulator capable of delivering general flight and spatial disorientation training.

Key Points: 
  • The GAT-HELO is ETC's most cost-effective, helicopter simulator capable of delivering general flight and spatial disorientation training.
  • The specialized GAT-HELO motion platform is designed to create in flight illusions authentically and safely.
  • Additionally, the capabilities of the device will contribute to research partnerships that will help improve aviation safety across the industry.
  • ETCs unique ability to offer complete systems, designed and produced to high technical standards, sets it apart from its competition.

Rasmussen University Offers Accelerated BSN Program With New Hybrid Schedule Option

Retrieved on: 
Tuesday, October 5, 2021
Nursing, University, Education, Health, Women, Men, Training, Consumer, Teens, Other Education, Continuing, Higher, Student, Suite, Higher Learning Commission, BSN, Rasmussen University, CCNE, Learning, Faculty, LaSalle Street, Commission on Collegiate Nursing Education, Program, COVID-19, Technology, North Dakota, Commission, Experiential learning, Education, Second degree, Medicine, Tutoring

Rasmussen University, a private university accredited by the Higher Learning Commission1, today announced its CCNE-accredited2, accelerated Bachelor of Science in Nursing (BSN) program now offers a new hybrid schedule option for qualified students enrolling in Rasmussens North Dakota and Wisconsin campuses.

Key Points: 
  • Rasmussen University, a private university accredited by the Higher Learning Commission1, today announced its CCNE-accredited2, accelerated Bachelor of Science in Nursing (BSN) program now offers a new hybrid schedule option for qualified students enrolling in Rasmussens North Dakota and Wisconsin campuses.
  • The intent of our new hybrid schedule option is to offer a quality, innovative BSN program to students who need more flexibility or may reside farther away from our campus.
  • Hybrid Schedule: The hybrid schedule includes online didactic courses and less commuting to campus.
  • Students in the accelerated BSN program will experience:
    For more information on the Rasmussen University accelerated BSN program and its new hybrid scheduling option, please visit Rasmussen.edu/bsnhybrid.

Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment

Retrieved on: 
Tuesday, September 21, 2021
Biotechnology, General Health, Health, Medical Devices, Degenerative disease, Adoption, Securities Act of 1933, BCBS, Henry Ford, Lung, Amerigroup, Security (finance), Drug Quality and Security Act, NASDAQ, U.S. Securities and Exchange Commission, FDA, Patient, Atmosphere, Global Initiative, MD, Chronic obstructive pulmonary disease, Corporation, GOLD, Blue Cross Blue Shield Association, Zephyr, Respiratory disease, Blues, Bronchoscopy, North Carolina, Securities Exchange Act of 1934, Health Care Service Corporation, North Dakota, Endobronchial valve, COPD, Safety, Han Lifei (d. 1424), Quality of life, SEC, Health insurance, Medical imaging, the Zephyr Valve Treatment, Pulmonx Corporation, THE ZEPHYR VALVE TREATMENT, PULMONX CORPORATION

This follows similar coverage decisions by other BCBS plans and now establishes positive coverage with the majority of BCBS covered members in the US (for an aggregate of 69 million covered lives).

Key Points: 
  • This follows similar coverage decisions by other BCBS plans and now establishes positive coverage with the majority of BCBS covered members in the US (for an aggregate of 69 million covered lives).
  • The Zephyr Valves are placed by bronchoscopy and are the first minimally invasive treatment option for patients who remain symptomatic despite medication and oxygen therapies.
  • The Zephyr Valve is a minimally invasive treatment option for severe COPD/emphysema, a chronic, progressive, and irreversible lung disease characterized by the destruction of lung tissue.
  • Pulmonx Corporation (NASDAQ: LUNG) is a global leader in minimally invasive treatments for severe lung disease.